Cannabis & Medicinal Research

About Conference

Euros Cannabis 2025 is pleased to invite researchers, clinicians, policymakers, entrepreneurs, and advocates from across the globe to participate in the “13th International Conference on Cannabis & Medicinal Research”, scheduled for November 27–28, 2025 in Amsterdam, Netherlands. This prestigious event offers a comprehensive platform to explore the rapidly evolving science and therapeutic potential of medicinal cannabis and cannabinoid-based treatments.

Theme: “Innovations and Insights in Medicinal Cannabis for Modern Medicine”

Euros Cannabis 2025 will spotlight the latest advancements in medical cannabis research, its clinical applications, pharmacology, regulatory considerations, and patient-centered practices. The conference aims to bridge the gap between research and real-world healthcare, fostering critical dialogue among stakeholders committed to responsible and evidence-based cannabis medicine.

The congress will feature in-depth keynote lectures, case-based discussions, symposia, technical workshops, and panel sessions on a wide range of topics including Cannabinoid Pharmacology, Clinical Trials, Cannabis for Neurological Disorders, Cancer Pain Management, Medical Marijuana Regulation, Cultivation & Extraction Techniques, Pediatric Applications, and Global Policy Trends.

As part of our commitment to encouraging new research, the event will also feature a Young Researcher Forum (YRF), providing early-career scientists with the opportunity to present their work and compete for Best Presentation, Best Poster, and Young Researcher Awards.

Why Attend?

• Stay updated on the latest evidence, innovations, and breakthroughs in medicinal cannabis.
• Participate in a robust scientific program with world-renowned cannabis researchers and clinicians.
• Gain insights into policy, legal frameworks, and commercialization of cannabis-based therapeutics.
• Engage in interactive discussions and network with experts across academia, healthcare, and the cannabis industry.
• Showcase your research and contribute to shaping the future of cannabis in medicine.

Welcome Message

Dear Speakers, Delegates, Exhibitors & Sponsors,

On behalf of the Organizing Committee, it is our distinct pleasure to welcome you to the “13^th International Conference on Cannabis & Medicinal Research”, taking place in Amsterdam, Netherlands on November 27–28, 2025.

This international congress serves as a vital platform for clinicians, researchers, healthcare practitioners, industry leaders, and policymakers dedicated to the scientific exploration and medical applications of cannabis and cannabinoid-based therapies. The event offers a unique opportunity to engage with the latest research, clinical innovations, and regulatory insights shaping the future of medicinal cannabis.

Over the course of two days, participants will benefit from keynote presentations, interactive discussions, and expert-led panels featuring internationally recognized leaders in the field. These sessions will explore emerging therapeutic potentials, address global policy shifts, and promote evidence-based approaches to cannabis in medicine.

We are confident that your participation will contribute to an enriching exchange of knowledge and foster impactful collaborations within this rapidly evolving domain. We look forward to welcoming you to Amsterdam this November for an insightful and forward-thinking experience at Cannabis Marijuana 2025.

For any queries regarding the conference, please contact Ms. Lila Prescott, Program Coordinator.

With warm regards,
Organizing Committee
Cannabis Marijuana 2025

Sessions and Track

1. Cannabinoid Pharmacology & Mechanisms of Action

Explore the foundational science behind how cannabinoids interact with the human endocannabinoid system (ECS). This session focuses on CB1 and CB2 receptors, receptor affinity, and how compounds like THC, CBD, and lesser-known cannabinoids affect neurological, immunological, and metabolic functions. Discussions will include dose-response relationships, pharmacokinetics, and mechanisms of action. Attendees will also gain insights into the entourage effect and the synergistic roles of terpenes and flavonoids. This session is essential for both researchers and clinicians seeking a deeper understanding of cannabis as medicine.

2. Medical Cannabis in Chronic Pain Management

This session explores the application of cannabis-based medicines for chronic pain relief, a leading area of therapeutic interest. Topics include mechanisms of analgesia, clinical trial outcomes, and real-world patient experiences in conditions such as neuropathy, fibromyalgia, arthritis, and cancer-related pain. Presenters will cover dosage titration, long-term safety, and comparison with opioid therapy. Attendees will examine multimodal strategies combining cannabis with physical therapy, behavioral interventions, and complementary medicine.

3. Cannabinoids in Neurological & Psychiatric Disorders

This track investigates the emerging evidence for cannabinoids in managing neurological and psychiatric conditions. Presentations will cover epilepsy, multiple sclerosis, Parkinson’s disease, Tourette’s syndrome, PTSD, depression, and anxiety disorders. Emphasis will be placed on neuroprotective effects, synaptic modulation, and mood regulation via the ECS. Clinicians will gain insights into patient selection, risk-benefit analysis, and therapeutic monitoring. Key challenges, such as adverse psychiatric reactions, will also be addressed.

4. Innovations in Cannabis Extraction & Formulation

Extraction and formulation are critical for therapeutic consistency and safety. This session focuses on advanced technologies like supercritical CO? extraction, ethanol processing, and solventless methods. Experts will discuss purity, cannabinoid ratios, and terpene preservation during processing. The session also explores innovative formulations such as nanoemulsions, liposomal carriers, transdermal patches, and sublingual sprays. Attendees will learn about challenges in standardization, GMP compliance, and scalability in pharmaceutical development.

5. Pediatric Applications & Ethical Considerations

Cannabis in pediatric care is gaining attention, particularly for conditions like treatment-resistant epilepsy, autism spectrum disorders, and palliative care. This session reviews clinical findings, case studies, and the ethical frameworks needed when treating children with cannabis. Presenters will discuss long-term safety, appropriate dosing, and parental decision-making. Regulatory challenges, societal concerns, and physician responsibilities will also be explored. This is a must-attend track for clinicians working in pediatric and family medicine.

6. Regulatory Affairs & Legal Frameworks Worldwide

Navigating the complex legal landscape of medical cannabis requires in-depth knowledge of country-specific frameworks. This session offers a comparative analysis of global regulatory systems, from full legalization to restrictive medical use. Topics include licensing processes, import/export rules, quality control standards, and prescription models. Experts will discuss barriers to market entry, harmonization efforts, and opportunities for global collaboration. Policymakers, manufacturers, and clinicians will benefit from legal clarity and compliance strategies

7. Cannabis and Cancer Symptom Management

Medical cannabis is increasingly integrated into oncology for symptom relief. This session covers evidence-based approaches to managing cancer-related pain, chemotherapy-induced nausea, appetite loss, anxiety, and insomnia. Presenters will examine real-world applications, safety concerns, and the integration of cannabis into standard oncology care. Early findings on cannabinoid anti-tumor effects and potential adjuvant therapy will be explored. Attendees will also learn about communication strategies with patients and families in palliative settings.

8. Agricultural Science, Cultivation & Sustainability

High-quality medicinal cannabis starts with optimal cultivation practices. This session covers plant genetics, strain selection, pest and disease control, and nutrient management. Experts will present strategies for both indoor and outdoor cultivation, highlighting environmental controls and yield optimization. Sustainable and organic farming practices, water conservation, and energy-efficient systems will be emphasized. Cultivators and manufacturers will gain insights into achieving consistent, contaminant-free, and potent cannabinoid profiles.

9. Clinical Trials & Evidence-Based Research

As cannabis-based medicine becomes mainstream, evidence from clinical trials is essential. This session addresses best practices in trial design, placebo controls, patient recruitment, and ethical approvals. Key trials in chronic pain, epilepsy, and psychiatric disorders will be presented, along with meta-analyses and observational studies. Attendees will learn how to interpret findings, translate them into practice, and contribute to evidence-based policy and treatment protocols. Regulatory expectations and publication strategies will also be discussed.

10. Endocannabinoid System: Science & Significance

The endocannabinoid system (ECS) plays a central role in regulating physiological processes such as pain, inflammation, mood, appetite, and sleep. This session offers an in-depth exploration of ECS components, including endogenous cannabinoids (anandamide, 2-AG), cannabinoid receptors, and degradation enzymes. Presenters will examine ECS dysregulation in various disease states and how phytocannabinoids restore balance. Understanding ECS is key to optimizing cannabinoid therapy and predicting patient responses.

11. Women’s Health and Medical Cannabis

This track focuses on cannabis applications in women’s health issues such as endometriosis, PMS, menopause, sexual dysfunction, and anxiety. Clinicians and researchers will present gender-specific clinical data and explore hormonal interactions with the ECS. Discussions will include individualized dosing, female-led research, and addressing stigma in female patient populations. This session encourages inclusive approaches to care and highlights emerging clinical trials targeting women's health.

12. Cannabis in Geriatric Medicine

Older adults are among the fastest-growing groups of cannabis users. This session examines its therapeutic use for chronic pain, insomnia, neurodegenerative conditions, arthritis, and mood disorders in elderly populations. Presenters will discuss challenges including altered metabolism, polypharmacy, cognitive effects, and patient education. Emphasis will be placed on safe dosing, caregiver support, and enhancing quality of life through personalized cannabis regimens.

13. Cannabinoid Delivery Systems & Product Innovation

Effective treatment requires optimal delivery. This session covers various methods including inhalation, oral ingestion, sublingual drops, topicals, suppositories, and transdermal patches. Experts will explore the pros and cons of each system in terms of onset time, duration, patient adherence, and bioavailability. Topics also include product innovation, formulation stability, and regulatory implications. Case examples will illustrate how delivery influences patient outcomes and therapeutic success.

14. Cannabis and Mental Health: Opportunities & Risks

Cannabis shows both therapeutic potential and risk in mental health treatment. This session explores its use for PTSD, anxiety, depression, and substance use disorders, while also addressing adverse effects like psychosis and dependency. Presenters will share clinical experiences, screening tools, and risk mitigation strategies. Discussions will focus on evidence-based use, informed consent, and developing mental health protocols that safely incorporate cannabis therapy.

15. Industrial Hemp and Non-Psychoactive Applications

This session highlights the growing economic and therapeutic potential of industrial hemp. Topics include CBD production, sustainable textile manufacturing, biodegradable plastics, and hempcrete in construction. Experts will differentiate regulatory classifications between hemp and cannabis, emphasizing low-THC cultivars. Attendees will explore the full value chain—from farming to finished product—and understand hemp’s role in advancing environmental goals and expanding wellness markets.

16. Cannabis Policy Reform and Public Health

As cannabis policy evolves, so do its implications for public health. This session analyzes the global shift from prohibition to regulation and its impact on community health, safety, and access. Presenters will discuss decriminalization, safe use education, harm reduction, and the social justice aspects of reform. Lessons from countries with legal frameworks will inform future directions. Attendees will also consider how research can guide effective, equitable policy.

17. Cannabis Research in Personalized Medicine

The future of cannabis therapy lies in personalization. This session explores how genetics, epigenetics, and metabolic factors influence individual responses to cannabinoids. Topics include pharmacogenomics, biomarker development, and AI-driven treatment algorithms. Case examples will demonstrate how personalized cannabis care can improve outcomes and reduce side effects. Attendees will learn how to integrate this approach into clinical workflows.

18. Cannabis Entrepreneurship & Market Trends

This track brings together innovators and investors to explore the booming global cannabis economy. Topics include market analytics, product innovation, branding, consumer trends, and investment strategies. Startups will learn how to navigate licensing, compliance, and international expansion. Case studies will showcase success stories and pitfalls in cannabis entrepreneurship. The session offers a roadmap for scaling sustainably in a competitive and highly regulated space.

19. Integrative Approaches: Cannabis in Holistic Care

Cannabis is increasingly used alongside holistic therapies to support wellness. This session explores integrative care models that combine cannabis with practices such as acupuncture, nutrition, yoga, meditation, and naturopathy. Presenters will discuss synergy, clinical outcomes, and how to personalize care based on individual needs. Attendees will gain tools to implement patient-centered, whole-body healing strategies using cannabis as a complementary therapy.

20. Young Researcher Forum & Emerging Investigators Track

This track provides an interactive platform for young scientists, graduate students, and early-career professionals to present innovative research in cannabis science and medicine. Presentations will be peer-reviewed, with awards for Best Poster and Best Oral Presentation. Participants will gain feedback from senior researchers and network with global experts. This forum encourages emerging talent, fosters mentorship, and highlights the next generation of cannabis leaders.

Participation/Presentation Options

Oral presentation: Oral Presentations may include the topics from researches, theoretical, professional or private practices in a concise manner. Individuals with personal experience are also welcome to present personal experiences or narratives which help others in everyday life. Speakers with a 30-minute slot should plan to speak for 20-25 minutes, and Keynote speakers should plan to speak for 40-45 minutes, with the remaining time to be used for questions and discussion by the Session Chair.

Workshop: For workshop presenters also, the topic of the talk will be the same as an Oral presentation with more specialized techniques and detailed demonstration. The generalized time duration for a workshop presentation is about 45-50 minutes. Interested participants can join with their respective team and present the workshop with their research coordinators with special group waivers on registration

Poster presentation: Student Poster Competition will be organized at the Nutrition Science 2025 conference is to encourage students and recent graduates to present their original research. Presenters will be given about 5-7 minutes to present the poster including questions and answers. Judges may ask questions during the evaluation of the presentation. This is an opportunity for young scientists to learn about the recent findings of their peers to increase their capacity as multidisciplinary researchers. Poster displays will be in hard copy format of 1x1 M long.

For more details regarding Poster Presentation and Judging Criteria view Poster Presentation Guidelines.

Webinar: The webinar presentation is designed for those interested attendees who cannot join in person due to schedule conflicts or other obligations. In this option, the presenter may record the presentation and their presentation will be presented in the Webinar presentation session

E-Poster: e-Poster is also similar to the webinar presentation. In this session, their presentation will be published in the form of a poster in the conference website and the presenter abstract will be published in the conference souvenir and journal with DOI.

Exhibition: Showcase your products, services, and innovations at Cannabis Marijuana 2025. We welcome exhibitors from cannabis pharma, research, cultivation, extraction, equipment, and healthcare sectors. Connect with global experts and industry leaders this November in Amsterdam.

To know more about exhibitor booth details and benefits visit WHY TO EXHIBIT WITH US?

Send your queries to neurologyconference@europeanmeets.com

Advertisement: The conference program is a valuable resource that all attendees refer again and again as they navigate the conference. Advertising in the conference program is a great way to market and can help you secure long term business.

Send your proposal to neurologyconference@europeanmeets.com to know the available advertisement options and prices

Sponsor Cannabis Marijuana 2025

Premium Sponsorship package

Visa Process

Visa Guidelines for the 13th International Conference on Cannabis & Medicinal Research Amsterdam, Netherlands | November 27–28, 2025

Planning to attend the “13th International Conference on Cannabis & Medicinal Research” in Amsterdam, Netherlands Here's a step-by-step guide to help you navigate the Schengen visa application process smoothly.

Step 1: Register for the Conference

Begin by completing your registration for the conference. Once confirmed, you will receive an official invitation letter—essential for supporting your visa application and stating the purpose of your visit.

Step 2: Identify Your Visa Type

Most international attendees will require a short-stay Schengen visa for the Netherlands, allowing a stay of up to 90 days for tourism, business, or conference participation.

Step 3: Prepare Required Documents

Typical documents include:

• Valid passport (minimum 3 months validity beyond return date)
• Completed visa application form
• Official invitation letter from the conference
• Flight and accommodation details
• Proof of financial means (bank statements, income proof)
• Travel insurance with medical and repatriation coverage for the Schengen area

Step 4: Book a Visa Appointment

Schedule an appointment with the Dutch embassy or consulate in your country. It’s best to do this early, as appointments fill quickly during high travel seasons.

Step 5: Attend the Interview

Attend your visa interview with all required documents. You may be asked about your visit purpose, travel plans, and home country ties to confirm your intent to return after the event.

Step 6: Visa Processing Time

Visa processing generally takes 10 to 15 business days, so apply at least a month before your travel date to avoid delays.

Step 7: Collect Your Visa

Once approved, collect your passport with the visa sticker. Verify all details and be sure to review any specific entry requirements for the Netherlands.

Abstract Submission Criteria & Eligibility

The Organizing Committee of the 13^th International Conference on Cannabis & Medicinal Research invites researchers, clinicians, scientists, policymakers, and industry professionals to submit abstracts for presentation at the conference. We welcome submissions covering all aspects of cannabis science, medicinal applications, clinical research, pharmacology, biotechnology, patient care, regulation, and cannabis-based innovation.

Presentation Requirements

All presenting authors must complete their registration and are responsible for their own travel and accommodation expenses. Upon acceptance, presenters will receive an official Letter of Acceptance via email, which can be used to proceed with registration and, if necessary, for visa application purposes. Accepted abstracts will be published in the Conference Abstract Book, available to all attendees during the event.

If the primary author is unable to attend the conference in person, a co-author or qualified colleague may present in their place. The Organizing Committee must be notified in advance to make program adjustments accordingly.

Submission Options

We offer the following presentation formats:

• Oral Presentations:
  Oral presentations will be grouped into thematic tracks related to cannabis and medicinal research. Each presenter will be given 30 minutes, including Q&A.
• Keynote Presentations:
  International leaders and trailblazers in the cannabis field will deliver 45-minute keynote sessions, providing visionary insights and expert perspectives.
• Workshops & Special Sessions:
  These 60-minute sessions will focus on clinical techniques, lab practices, product innovations, regulatory compliance, or case-based discussions with interactive components.
• Symposium Sessions:
  These collaborative 60-minute sessions will center on specific, high-impact topics within the cannabis field, followed by 5 minutes of audience Q&A to encourage dialogue and exchange.

Market Analysis

Global Growth of Medicinal Cannabis

The global medicinal cannabis market is experiencing remarkable expansion, with its value projected to rise from USD 20.4 billion in 2024 to over USD 57 billion by 2032, growing at a CAGR of around 14.2%. This surge is fueled by increasing legalization, supportive regulations, and growing clinical acceptance of cannabis-based therapies for conditions such as chronic pain, epilepsy, anxiety, and cancer-related symptoms. Countries across Europe, North America, and Latin America are leading in medical cannabis adoption, opening up vast opportunities for research, development, and pharmaceutical integration.

Rising Demand for Cannabis-Based Therapies

As patient demand grows for alternative and plant-based treatment options, cannabis-derived medicines are gaining traction across various therapeutic areas. The expanding body of clinical evidence supporting cannabinoids, coupled with innovation in product formulation, delivery methods, and extraction technologies, is driving significant investment and market entry. This trend signals a promising future for ongoing research, global collaboration, and the development of standardized, effective cannabis-based treatments.